To explore the clinical relevance of the expression patterns of GP78 and PD-L1 in various types of cancer, we examined publicly available immunohistochemistry (IHC) data from the Human Protein Atlas (HPA) using antibodies CAB026381 (GP78) and CAB080537 (PD-L1). The gene discussed is AMFR; the disease is cancer.